The logistical aspects of developing testing kits, treatments, and vaccinations for COVID-19 have been captured in business documents. A few of the industry leader names, such as Regeneron, Pfizer, and Moderna, are already well-known yet there are many other companies involved with handling the licensing, manufacturing, distribution, and legal management of implementing these services across the United States and the world.
RealDealDocs saves hours of drafting time (each document can be edited) and incorporates business documents written by leading lawyers, business executives, and innovators – providing you with insight and a competitive edge. Visit RealDealDocs to view the first page of each document at no charge.
Here are some of the latest documents available in the RealDealDocs database surrounding the business of COVID-19:
Regeneron Pharmaceuticals License Agreement
License Agreement for REGENERON PHARMACEUTICALS, INC., F Hoffmann-La Roche Ltd, Genentech, Inc, Regeneron Pharmaceuticals, Inc
Oragenics Development & Manufacturing Agreement
Tonix Pharmaceuticals Collaboration & License Agreement
Tonix Pharmaceuticals Enters Into Research Collaboration And Exclusive License Agreement With University Of Alberta To Develop Novel Horsepox-Based Vaccines, Tnx-1810, Tnx-1820 And Tnx-1830, For The Prevention Of Covid-19 for TONIX PHARMACEUTICALS HOLDING CORP., Tonix Pharmaceuticals Holding Corp
Precheck Health COVID-19 Test Distribution
Precheck Health Announces 3 Rd Coronavirus Covid-19 Pcr Test Distribution Agreement for PRECHECK HEALTH SERVICES, INC., Co-Diagnostics Inc, Health Tech Innovation Systems, Inc, PreCheck Health Services, Inc
Image courtesy of Wilfried Pohnke